Skip to Main Content

Paper Details

Selecting patients with HER2-low breast cancer: Getting out of the tangle.
Eur J Cancer
14
2022
Author NameAffiliation
Jochen K LennerzCenter for Integrated Diagnostics, Massachusetts General Hospital/Harvard Medical School
John M S BartlettInstitute of Genetics and Cancer, The University of Edinburgh
Carolien H M van Deurzen
  • 1 - 3

Datasets

Release 1.2